Obstructive Sleep Apnea (OSA) is a severe chronic disease that causes people to stop breathing while they sleep.

The most common treatment prescribed for OSA is a technology invented over 40 years ago – CPAP (Continuous Positive Airway Pressure) – which causes many patient complaints1 and has low adherence rates.1,2

In contrast, TherapneaTM is our new and unique OSA therapy device that overcomes CPAP therapy compliance problems through patented innovations and a disruptive approach to OSA treatment.

Our Proof of Concept (POC) clinical study validated the concept while demonstrating that our TherapneaTM technology prevented apnea events.